COMPANIES
Welcome to the ADDF/Alzforum Drug Discovery Database. This resource is intended to assist basic scientists who would like to develop their discoveries into diagnostics and therapies. The database contains information on companies that offer products and services for translational research, such as assay development, drug libraries, drug screening, computational modeling and consultation on biotech startups. The database also includes pharmaceutical, reagent, research model, and biotech companies that are involved in and support the development of Alzheimer therapies. The Alzforum thanks the Institute for the Study of Aging for its generous financial support and technical and scientific advice on the database and tutorial.


DRUG DEVELOPMENT TUTORIAL
The ADDF/Alzforum Drug Discovery Tutorial provides an introduction for academics and other researchers who are new to the field of drug discovery. The tutorial outlines fundamental concepts and processes of drug discovery. Our goal is to guide researchers toward the steps necessary to translate benchside findings into bedside applications, and to locate resources that can help provide reagents and services needed in this process.


DRUGS IN CLINICAL TRIALS
Some two dozen compounds are currently in clinical trials, and more are coming into the pipeline every year. We track all compounds that have reached Phase II (that is, they have passed Phase I safety trials). Although by definition these are not yet proved to be effective, they offer added possibilities for treatment.